XBiotech USA Growth, Revenue, Number of Employees and Funding

Overview

Location:
Austin, TX USA
Total Funding:N/A
Industry:Biotech
Founded:2005
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • XBiotech USA's estimated revenue is currently $10.9M per year.
  • XBiotech USA's estimated revenue per employee is $144667

Employee Data

  • XBiotech USA has 75 Employees.
  • XBiotech USA grew their employee count by 12% last year.
  • XBiotech USA currently has N/A job openings.

Executive Contacts

NameTitle
John SimardFounder, President, CEO & Chairman
Queena HanVice President, Finance and Human Resources and Secretary (Principal Financial Officer)
Qian WuVP of Quality Control
Edwin VeraFacilities Director
Rodney BowlingDirector of Molecular Genetics
Steve AntonakesIT Director
Sushma ShivaswamyChief Scientific Officer
Rodney Bowling Jr.Director of Molecular Genetics
Mark WilliamsMedical Director

What Is XBiotech USA?

XBiotech is developing a first-in-class monoclonal antibody (MABp1) to inhibit chronic inflammation. Chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. MABp1 is being investigated in many important areas of medicine, including: cancer, leukemia (Phase 1); Type 2 diabetes (Phase2); Psoriasis (Phase 2); and vascular disease (Phase 2). MABp1 is a True Human antibody cloned from a natural human immune response andunlike currently marketed antibodiesit has not undergone any modification to alter its function. It has exhibited the best potential tolerability and safety during the clinical trials. XBiotech has established a current good manufacturing practices (cGMP) program to commercialize its lead product candidate. The Company has purchased land and designed a commercial-scale plant with 25,000L total bioreactor capacity. Construction of the facility is planned to commence in 4th quarter 2011..

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

75

Number of Employees

$10.9M

Revenue (est)

N/A

Current Jobs

12%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Bellicum Pharma...
$1.1M148-11%$301.8M
G-CON Manufactu...
$8.8M6133%
BioNews Service...
$8.7M6011%
Luminex Corpora...
$158.4M109410%
Family Tree DNA
$5.7M4018%
XBiotech USA
$10.9M7512%
Celling Bioscie...
$9M62-2%
Gradalis
$6.2M4343%$40M
Myriad RBM
$16.7M1167%
Selleck Chemica...
$22M1528%

XBiotech USA News

06/26/2019 - XBiotech Wins “Commercial Real Estate Award for Industrial ...

XBiotech USA Inc. received the award for its integrated R&D, administrative, and manufacturing facility located just 15 minutes from downtown ...

09/03/2019 - Cancer Cachexia Market will likely see excellent gains in key ...

Global Cancer Cachexia Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use is latest research study ...

05/08/2019 - Austin's best new buildings, deals: Winners named in 2019 ...

A "green living" concept served as the guiding vision of the Southeast Austin campus of biosciences company XBiotech USA Inc.. The $21.4 ...